Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.220
-0.020 (-0.89%)
At close: Dec 5, 2025, 4:00 PM EST
2.250
+0.030 (1.35%)
After-hours: Dec 5, 2025, 5:15 PM EST
Aytu BioPharma Employees
As of June 30, 2025, Aytu BioPharma had 83 total employees, including 82 full-time and 1 part-time employees. The number of employees decreased by 16 or -16.16% compared to the previous year.
Employees
83
Change (1Y)
-16
Growth (1Y)
-16.16%
Revenue / Employee
$767,422
Profits / Employee
-$157,482
Market Cap
22.62M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AYTU News
- 12 days ago - Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference - Accesswire
- 23 days ago - Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results - Accesswire
- 4 weeks ago - Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025 - Accesswire
- 5 weeks ago - Aytu BioPharma Announces Patent Term Extension for EXXUA(TM) - Accesswire
- 2 months ago - Aytu BioPharma to Present at Upcoming October 2025 Conferences - Accesswire
- 2 months ago - Aytu BioPharma to Present at Upcoming September 2025 Conferences - Accesswire
- 2 months ago - Aytu BioPharma, Inc. (AYTU) Q4 2025 Earnings Call Transcript - Seeking Alpha